Gary N. Frishman, MD, has been appointed to the Residency Review Committee for Obstetrics and Gynecology of the Accreditation Council for Graduate Medical Education (ACGME). Dr. Frishman is the associate director of the Division of Reproductive Endocrinology and Infertility and Residency Program Director at Women & Infants Hospital of Rhode Island and The Warren Alpert Medical School of Brown University, where he is also a professor of obstetrics and gynecology.
The mission of the ACGME is to improve health care by assessing and advancing the quality of resident physicians’ education. The Residency Review Committee is responsible for setting accreditation standards, providing peer evaluation of programs or institutions to assess compliance with published educational standards, and conferring accreditation status for programs and institutions that meet those standards. The committee members are nominated by the American Medical Association (AMA), the American Board of Obstetrics and Gynecology (ABOG) and the American College of Obstetrics and Gynecology (ACOG).
Dr. Frishman received his undergraduate degree from the University of Pennsylvania and attended medical school at Columbia University in New York City. He completed a residency in obstetrics and gynecology at Pennsylvania Hospital in Philadelphia and a fellowship in reproductive endocrinology and infertility at the University of Connecticut.
Dr. Frishman is actively involved in surgical societies and has served on the board of the AAGL, the American Society of Reproductive Medicine, and the Fellowship in Minimally Invasive Gynecologic Surgery. He has served as president of both the Society of Reproductive Surgeons and the Council on Gynecologic Excellence. He is the deputy editor of the Journal of Minimally Invasive Gynecology. He previously served as the American representative on the International Editorial Board for the UK journal: The Obstetrician and Gynaecologist and currently serves as an oral board examiner for the American Board of Obstetrics and Gynecology. He has created and runs a LISTSERV on topics in minimally invasive surgery for AAGL which has more than 6,400 members.
Locally, Dr. Frishman has been on the boards of Big Sisters of Rhode Island and Day One, serving as vice presidents for both of those organizations.
About Women & Infants Hospital
Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation’s leading specialty hospitals for women and newborns. A major teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women’s medicine, Women & Infants is the eighth largest stand-alone obstetrical service in the country with nearly 8,400 deliveries per year. A U.S.News 2014-15 Best Children’s Hospital in Neonatology, in 2009, Women & Infants opened the country’s largest, single-family room neonatal intensive care unit.
New England’s premier hospital for women and newborns, Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s only mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Center of Excellence from the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center for In Vitro Maturation Excellence by SAGE In Vitro Fertilization; a Center of Biomedical Research Excellence by the National Institutes of Health; and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the National Institutes of Health’s Pelvic Floor Disorders Network.